SAPOZHNIKOVA, T.A.,
BORISEVICH, S.S.,
KIREEVA, D.R.,
GABDRAKHMANOVA, S.F.,
KHISAMUTDINOVA, R.Y.,
MAKARA, N.S.,
GIBADULLINA, N.N.,
KHURSAN, S.L.,
ZARUDII, F.S. (2019) and to evaluate thesecompounds for their
potential antihypoxic and antioxidant action on normobaric hypercapnic
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) , to act as therapeutic targets, and to identify
potential small-molecule compounds for treating ICH
by this defense system have
potentiated the activity of ribozymes in the composition of ribonucleoproteins (RNPs
Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) in action
potential generation and cardiac contraction, Ca2+ channels and Ca2+ handling proteins represent